HomepageMedicineAmylyx Names New Chief Commercial Officer Ahead of GLP-1 Commercialization Medicine Amylyx Names New Chief Commercial Officer Ahead of GLP-1 Commercialization admin Posted on January 10, 2025 Dan Monahan will serve in the role as the drug goes through Phase III trials. LEAVE A RESPONSE Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment. admin View all posts Post navigation Previous PostIs My White Cat, Clutch, Deaf? Explaining Feline Genetics & Hearing Impairment Next PostHoliday Decorations in January? A Tennessee Woman Is Going to Court for Them. You Might Also Like Medicine The Bottlenecks Blocking Cell and Gene Therapy admin January 17, 2025 Medicine Pharma Pulse 7/23/24: Post-Roe, How Safe are Period-Tracking Apps? Where to Invest in Health Trends & more admin July 23, 2024 Medicine FDA Accepts Otsuka and Lundbeck’s Supplemental New Drug Application for Brexpiprazole to Treat Adults with Post-Traumatic Stress Disorder admin June 27, 2024 Medicine Lene Oddershede Discusses Upcoming Projects from the Novo Nordisk Foundation admin April 22, 2024
Medicine Pharma Pulse 7/23/24: Post-Roe, How Safe are Period-Tracking Apps? Where to Invest in Health Trends & more admin July 23, 2024
Medicine FDA Accepts Otsuka and Lundbeck’s Supplemental New Drug Application for Brexpiprazole to Treat Adults with Post-Traumatic Stress Disorder admin June 27, 2024
Medicine Lene Oddershede Discusses Upcoming Projects from the Novo Nordisk Foundation admin April 22, 2024